Linalyl acetate
Based on 1 publication(s) in Google Scholar
Linalyl acetate is the principal components of many plant essential oils. Linalyl acetate exhibits anti-anxiety, anti-inflammatory, anti-diabetic, anti-stress, and cardiovascular-regulatory effects. Linalyl acetate is orally active.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 98.80%
- No. CAS: 115-95-7
- Fòrmula: C12H20O2
- Peso molecular:196.29
-
Almacenamiento:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Linalyl acetate
More
Actividad biológica
Linalyl acetate (1-100 mg/kg, ip, single dose) reduces the heart rate and LDH activity, relieves vasoconstriction. Linalyl acetate alleviates the cardiovascular and cell damage caused by acute nicotine exposure in mouse models[3].
Linalyl acetate (100 mg/kg, ip, twice weekly for 5 weeks) regulates the expression of inflammatory mediators, prevents mitochondrial dysfunction, exhibits anti-inflammatory and anti-fibrotic effects in rats collagen II-induced arthritis (CIA) models[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Swiss albino mouse model[2].
-
Dosage:400 mg/kg
-
Administration:po, once daily for 15 days
-
Result:Increased the time and number of entries in the open arm or bright chamber in the elevated plus maze and light-dark box tests.
Increased the motor activity in the open field test and the activity photoelectric instrument test.
-
Animal Model:Acute nicotine exposure in mouse models[3]
-
Dosage:1-100 mg/kg
-
Administration:ip, single dose
-
Result:Reduced LDH activity, inhibited relaxation of mouse aortic rings, and improved the nitric oxide (NO) level in serum.
-
Animal Model:Collagen II-induced arthritis (CIA) rats models[4]
-
Dosage:100 mg/kg
-
Administration:ip, twice weekly for 5 weeks
-
Result:Inhibited the increase in hind paw thickness, reduced serum IL-6 level, increased the gastrocnemius muscle weight and fiber cross-sectional area.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 115-95-7
-
Appearance Liquid (Density: 0.8997 g/cm3)
-
Peso molecular 196.29
-
Fòrmula C12H20O2
-
Color Colorless to light yellow
-
SMILES
CC(OC(CC/C=C(C)\C)(C)C=C)=O
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cell Rep
2024 Oct 3;43(10):114800. PMID: 39365703
Solvente y solubilidad
DMSO : 100 mg/mL (509.45 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (12.74 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (12.74 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (274 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. A.T. Peana, et al. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils,Phytomedicine. 2002 Dec;9(8):721-6. [Content Brief]
[3]. Kim JR, et al., Cardiovascular effects of linalyl acetate in acute nicotine exposure. Environ Health Prev Med. 2017 Apr 24;22(1):42. [Content Brief]
[4]. Seo E, et al., Linalyl acetate as a potential preventive agent against muscle wasting in rheumatoid arthritis rats chronically exposed to nicotine. J Pharmacol Sci. 2021 Sep;147(1):27-32. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.0945 mL | 25.4725 mL | 50.9450 mL | 127.3626 mL |
| 5 mM | 1.0189 mL | 5.0945 mL | 10.1890 mL | 25.4725 mL | |
| 10 mM | 0.5095 mL | 2.5473 mL | 5.0945 mL | 12.7363 mL | |
| 15 mM | 0.3396 mL | 1.6982 mL | 3.3963 mL | 8.4908 mL | |
| 20 mM | 0.2547 mL | 1.2736 mL | 2.5473 mL | 6.3681 mL | |
| 25 mM | 0.2038 mL | 1.0189 mL | 2.0378 mL | 5.0945 mL | |
| 30 mM | 0.1698 mL | 0.8491 mL | 1.6982 mL | 4.2454 mL | |
| 40 mM | 0.1274 mL | 0.6368 mL | 1.2736 mL | 3.1841 mL | |
| 50 mM | 0.1019 mL | 0.5095 mL | 1.0189 mL | 2.5473 mL | |
| 60 mM | 0.0849 mL | 0.4245 mL | 0.8491 mL | 2.1227 mL | |
| 80 mM | 0.0637 mL | 0.3184 mL | 0.6368 mL | 1.5920 mL | |
| 100 mM | 0.0509 mL | 0.2547 mL | 0.5095 mL | 1.2736 mL |
Linalyl acetate Related Classifications
HY-N6948 Related Classifications
Powered by Bioz